Ex-Google exec said goal was to ‘crush’ competition, trial evidence shows

By Jody Godoy ALEXANDRIA, Virginia (Reuters) – A Google executive told colleagues the goal for the company’s then-nascent online advertising business in 2009 was to “crush” rival advertising networks, according to evidence prosecutors presented at the tech titan’s antitrust trial on Wednesday. The statements underscored the U.S. Department of Justice’s claim that Google has sought…

Read More

New York recovers $50 million for defrauded Gemini Earn crypto investors

By Jonathan Stempel NEW YORK (Reuters) – New York Attorney General Letitia James said on Friday her office has recovered $50 million from the cryptocurrency platform Gemini Trust to repay investors defrauded in its Gemini Earn program. James said Gemini, run by billionaire twin brothers Cameron and Tyler Winklevoss, will provide full recoveries to more…

Read More

North Korea denounces declaration at NATO summit, KCNA says

SEOUL (Reuters) -North Korea “most strongly denounces” the declaration at the recent NATO summit, KCNA said on Saturday, citing the country’s foreign ministry spokesperson. Leaders of NATO countries stressed a membership pledge for Ukraine and took a stronger stance on China’s support for Russia in a declaration this week at a summit in Washington. “The…

Read More

AbbVie’s tight grip on Humira market raises concerns about biosimilars

By Patrick Wingrove (Reuters) – AbbVie’s top-selling arthritis drug Humira has held onto more than 80% of patients after facing nine lower-priced rivals in the U.S. in the last year, raising questions about whether the market for prescription biosimilars can survive in its current form, drug pricing experts and analysts say. Humira, which lists for…

Read More